4.8 Article

Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy

Journal

CHEMICAL SCIENCE
Volume 10, Issue 29, Pages 6932-6943

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c9sc02107h

Keywords

-

Funding

  1. National Basic Research Program of China [2016YFA2021600]
  2. National Natural Science Foundation of China [51822207, 51772292, 31571015, 11621505]
  3. Chinese Academy of Sciences Youth Innovation Promotion Association [2013007]
  4. CAS Key Research Program of Frontier Sciences [QYZDJ-SSW-SLH022]

Ask authors/readers for more resources

Radiotherapy (RT) is one of the most effective and frequent clinical cancer treatments. Nevertheless, RT can cause damage to normal tissues around tumors under high-dose ionizing radiation. Inspired by versatile metal-based nanomaterials, great efforts have been devoted to developing nanomaterials with high-Z metal elements as radiosensitizers by depositing more energy into tumors for RT enhancement. However, these metal-based nanomaterial-mediated RTs are highly O-2-dependent. Unfortunately, O-2 concentrations within the majority of solid tumors exhibit low levels, which seriously hampers the antitumor efficacy of these nanomaterials during RT. Therefore, the development of novel metal-based nanomaterials as radiosensitizers capable of avoiding the radioresistance induced by tumor hypoxia is highly desirable and important. Currently, the most effective approaches to reverse the radioresistance of hypoxic tumors are to introduce nanomaterials with O-2-elevating ability by delivering exogenous O-2, generating O(2)in situ, increasing intratumoral blood flow, or reducing HIF-1 expression to harness the O-2 level in solid tumors. Besides these, recently, some innovative and simple strategies by employing nanoradiosensitizers with diminished oxygen dependence have also been applied to combat unmet hypoxic challenges, in which nanoradiosensitizers can target tumor hypoxia for selective RT, enhance oxygen-independent ROS generation, or combine with non-oxygen dependent cancer therapies for synergistic treatments. These approaches and strategies provide new avenues for enhanced hypoxic-tumor RT. Nevertheless, an overall review aiming specifically at these strategies is still rare. Herein, we present an overview about recent advances in metal-based nanomaterials for hypoxic-tumor RT, and give a detailed discussion about the design and working mechanisms of these strategies in their application of RT. Finally, current challenges and future perspectives are also pointed out in this field.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available